# OnCo record breast-carcinoma-medullary-pattern (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/breast-carcinoma-medullary-pattern/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "breast-carcinoma-medullary-pattern" ;
  schema:name "Invasive breast carcinoma with medullary pattern (medullary carcinoma)"@en ;
  schema:alternateName "Medullary carcinoma"@en, "Medullary breast carcinoma"@en, "Medullary carcinoma of the breast"@en, "Atypical medullary carcinoma"@en, "Carcinoma with medullary features"@en, "Medullary-like carcinoma"@en ;
  schema:description "Medullary carcinoma is a form of breast cancer with high-grade cells growing in sheets and a dense crowd of immune cells around them. It looks alarming under the microscope and is usually triple-negative, yet it has a better outlook than other triple-negative cancers. Since 2019 it is classed as invasive breast cancer with a medullary pattern and treated as triple-negative disease."@en ;
  schema:url <https://onco.cc/cancers/breast-carcinoma-medullary-pattern/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Medullary_breast_carcinoma> ;
  schema:citation <https://doi.org/10.1111/his.14091>, <https://doi.org/10.1038/modpathol.2010.123>, <https://doi.org/10.30476/ijms.2017.40545> ;
  onco:tag "subtype-page", "wave4", "breast" ;
  onco:related <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-early/>, <https://onco.cc/cancers/invasive-breast-carcinoma-no-special-type/>, <https://onco.cc/cancers/metaplastic-breast-carcinoma/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:standardOfCare <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-early/>, <https://onco.cc/cancers/tnbc-metastatic/>, <https://onco.cc/drugs/pembrolizumab/> .